Mark A. Deeg

5.2k total citations · 2 hit papers
84 papers, 4.1k citations indexed

About

Mark A. Deeg is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mark A. Deeg has authored 84 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Mark A. Deeg's work include Trypanosoma species research and implications (13 papers), Diabetes Treatment and Management (12 papers) and Lysosomal Storage Disorders Research (11 papers). Mark A. Deeg is often cited by papers focused on Trypanosoma species research and implications (13 papers), Diabetes Treatment and Management (12 papers) and Lysosomal Storage Disorders Research (11 papers). Mark A. Deeg collaborates with scholars based in United States, United Kingdom and Germany. Mark A. Deeg's co-authors include David W. Crabb, Naga Chalasani, Monika Fischer, Min You, Haoda Fu, Meng H. Tan, David E. Moller, Anthony J. Zagar, Scott J. Jacober and David M. Kendall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mark A. Deeg

84 papers receiving 4.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

2013 730 citations Mark A. Deeg et al. profile →
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 626 citations Mark A. Deeg, Meng H. Tan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark A. Deeg	1.9k	1.5k	1.2k	945	725	84	4.1k
Toshiro Sugimoto	2.1k 1.1×	907 0.6×	784 0.7×	610 0.6×	843 1.2×	100	5.3k
Martin Ridderstråle	1.4k 0.8×	1.4k 0.9×	1.2k 1.0×	615 0.7×	1.1k 1.5×	84	3.7k
Yoshihiko Nishio	1.8k 1.0×	1.2k 0.8×	763 0.6×	879 0.9×	1.4k 2.0×	154	5.2k
I. George Fantus	2.2k 1.2×	925 0.6×	509 0.4×	676 0.7×	903 1.2×	66	4.5k
Kazunori Utsunomiya	1.3k 0.7×	1.6k 1.1×	624 0.5×	807 0.9×	582 0.8×	152	4.0k
Hideaki Miyoshi	1.4k 0.8×	946 0.6×	1.7k 1.5×	1.5k 1.5×	1.6k 2.2×	164	5.0k
Yukiko Onishi	1.6k 0.8×	1.6k 1.1×	745 0.6×	692 0.7×	890 1.2×	76	3.7k
Agata Maria Rabuazzo	911 0.5×	1.3k 0.9×	711 0.6×	1.2k 1.2×	595 0.8×	91	3.0k
Kazuhisa Tsukamoto	1.6k 0.9×	723 0.5×	911 0.8×	960 1.0×	436 0.6×	103	3.5k
Robin P.F. Dullaart	1.0k 0.5×	2.3k 1.5×	1.1k 0.9×	1.6k 1.7×	571 0.8×	188	4.8k

Countries citing papers authored by Mark A. Deeg

Since Specialization

Citations

This map shows the geographic impact of Mark A. Deeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Deeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Deeg more than expected).

Fields of papers citing papers by Mark A. Deeg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Deeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Deeg. The network helps show where Mark A. Deeg may publish in the future.

Co-authorship network of co-authors of Mark A. Deeg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Deeg. A scholar is included among the top collaborators of Mark A. Deeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Deeg. Mark A. Deeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dreyer, Rachel P., Alyssa Berkowitz, H. Klar Yaggi, et al.. (2022). Pre S cription Digita L Th E rap E utic for P atients with I nsomnia ( SLEEP-I ): a protocol for a pragmatic randomised controlled trial. BMJ Open. 12(8). e062041–e062041. 2 indexed citations

Luderer, Hilary F., Lisa M. Chiodo, Christina Brezing, et al.. (2021). Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial. JMIR Research Protocols. 11(1). e32759–e32759. 3 indexed citations

Smith, Claire, Yan Jin, Eyas Raddad, et al.. (2016). Applications of Bayesian statistical methodology to success criteria: A case study of a phase 2 design with interim futility assessment in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 24. S185–S185. 1 indexed citations

Jin, Yan, Claire Smith, David Monteith, et al.. (2016). LY2951742, a monoclonal antibody against CGRP, failed to reduce signs and symptoms of knee osteoarthritis. Osteoarthritis and Cartilage. 24. S50–S50. 11 indexed citations

Raikwar, Nandita S., et al.. (2010). Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance. Metabolism. 59(10). 1413–1420. 23 indexed citations

Deeg, Mark A. & Meng H. Tan. (2008). Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head‐to‐Head Randomized Clinical Studies. PPAR Research. 2008(1). 520465–520465. 40 indexed citations

O’Brien, Kevin D., et al.. (2008). Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women. Metabolism. 57(4). 473–478. 12 indexed citations

Deeg, Mark A., et al.. (2007). Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D. Translational research. 150(3). 153–157. 8 indexed citations

Murrell, Jill R., Olusegun Baiyewu, Oye Gureje, et al.. (2006). The fourth apolipoprotein E haplotype found in the Yoruba of Ibadan. PMC. 1 indexed citations

10.

Dominguez, Jesus H., Pengfei Wu, John W. Hawes, et al.. (2006). Renal injury: Similarities and differences in male and female rats with the metabolic syndrome. Kidney International. 69(11). 1969–1976. 38 indexed citations

11.

Deeg, Mark A.. (2005). Basic Approach to Managing Hyperglycemia for the Nonendocrinologist. The American Journal of Cardiology. 96(4). 37–40. 8 indexed citations

12.

Considine, Robert V., Fred R. Sattler, Mark A. Deeg, et al.. (2004). Changes in Thrombolytic and Inflammatory Markers After Initiation of Indinavir- or Amprenavir-Based Antiretroviral Therapy. Cardiovascular Toxicology. 4(2). 179–168. 7 indexed citations

13.

Chalasani, Naga, et al.. (2003). Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. The American Journal of Gastroenterology. 98(8). 1849–1855. 57 indexed citations

14.

Deeg, Mark A., et al.. (2002). Phosphorylation decreases trypsin activation and apolipoprotein AI binding to glycosylphosphatidylinositol-specific phospholipase D. Biochemistry and Cell Biology. 80(2). 253–260. 4 indexed citations

15.

Deeg, Mark A., et al.. (1999). Midportion Antibodies Stimulate Glycosylphosphatidylinositol-Specific Phospholipase D Activity. Archives of Biochemistry and Biophysics. 370(2). 278–284. 7 indexed citations

16.

Guo, Yao, et al.. (1998). Mouse glycosylphosphatidylinositol-specific phospholipase D ( Gpld1 ) characterization. Mammalian Genome. 9(9). 710–714. 35 indexed citations

17.

Deeg, Mark A. & Michael A. Davitz. (1995). [45] Glycosylphosphatidylinositol-phospholipase D: A tool for glycosylphosphatidylinositol structural analysis. Methods in enzymology on CD-ROM/Methods in enzymology. 250. 630–640. 21 indexed citations

18.

Deeg, Mark A. & Kumar Rajamani. (1990). Normeperidine-Induced Seizures in Hereditary Coproporphyria. Southern Medical Journal. 83(11). 1307–1308. 6 indexed citations

19.

Dawis, Stevan M., Timothy F. Walseth, Mark A. Deeg, et al.. (1989). Adenosine triphosphate utilization rates and metabolic pool sizes in intact cells measured by transfer of 18O from water. Biophysical Journal. 55(1). 79–99. 25 indexed citations

20.

Deeg, Mark A., Richard Graeff, Timothy F. Walseth, & N D Goldberg. (1988). A Ca2+-linked increase in coupled cAMP synthesis and hydrolysis is an early event in cholinergic and beta-adrenergic stimulation of parotid secretion.. Proceedings of the National Academy of Sciences. 85(21). 7867–7871. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact